289 related articles for article (PubMed ID: 28476373)
41. Molybdenum cluster loaded PLGA nanoparticles: An innovative theranostic approach for the treatment of ovarian cancer.
Brandhonneur N; Hatahet T; Amela-Cortes M; Molard Y; Cordier S; Dollo G
Eur J Pharm Biopharm; 2018 Apr; 125():95-105. PubMed ID: 29355686
[TBL] [Abstract][Full Text] [Related]
42. Enhancing the in vitro anti-cancer efficacy of artesunate by loading into poly-D,L-lactide-co-glycolide (PLGA) nanoparticles.
Nguyen HT; Tran TH; Kim JO; Yong CS; Nguyen CN
Arch Pharm Res; 2015; 38(5):716-24. PubMed ID: 24968925
[TBL] [Abstract][Full Text] [Related]
43. A new therapeutic avenue for bronchiectasis: Dry powder inhaler of ciprofloxacin nanoplex exhibits superior ex vivo mucus permeability and antibacterial efficacy to its native ciprofloxacin counterpart.
Tran TT; Vidaillac C; Yu H; Yong VFL; Roizman D; Chandrasekaran R; Lim AYH; Low TB; Tan GL; Abisheganaden JA; Koh MS; Teo J; Chotirmall SH; Hadinoto K
Int J Pharm; 2018 Aug; 547(1-2):368-376. PubMed ID: 29886096
[TBL] [Abstract][Full Text] [Related]
44. Spray-dried multidrug particles for pulmonary co-delivery of antibiotics with N-acetylcysteine and curcumin-loaded PLGA-nanoparticles.
Lababidi N; Montefusco-Pereira CV; de Souza Carvalho-Wodarz C; Lehr CM; Schneider M
Eur J Pharm Biopharm; 2020 Dec; 157():200-210. PubMed ID: 33222771
[TBL] [Abstract][Full Text] [Related]
45. Externally controlled triggered-release of drug from PLGA micro and nanoparticles.
Hua X; Tan S; Bandara HM; Fu Y; Liu S; Smyth HD
PLoS One; 2014; 9(12):e114271. PubMed ID: 25479357
[TBL] [Abstract][Full Text] [Related]
46. Cytotoxic and Bactericidal Effects of Inhalable Ciprofloxacin-Loaded Poly(2-ethyl-2-oxazoline) Nanoparticles with Traces of Zinc Oxide.
Sabuj MZR; Huygens F; Spann KM; Tarique AA; Dargaville TR; Will G; Wahab MA; Islam N
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901963
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of ciprofloxacin-loaded Eudragit RS100 or RL100/PLGA nanoparticles.
Dillen K; Vandervoort J; Van den Mooter G; Ludwig A
Int J Pharm; 2006 May; 314(1):72-82. PubMed ID: 16600538
[TBL] [Abstract][Full Text] [Related]
48. Poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) nanoparticles for local delivery of paclitaxel for restenosis treatment.
Westedt U; Kalinowski M; Wittmar M; Merdan T; Unger F; Fuchs J; Schäller S; Bakowsky U; Kissel T
J Control Release; 2007 May; 119(1):41-51. PubMed ID: 17346845
[TBL] [Abstract][Full Text] [Related]
49. PLGA Nanoparticles as Subconjunctival Injection for Management of Glaucoma.
Salama HA; Ghorab M; Mahmoud AA; Abdel Hady M
AAPS PharmSciTech; 2017 Oct; 18(7):2517-2528. PubMed ID: 28224390
[TBL] [Abstract][Full Text] [Related]
50. Parenteral immunization of PLA/PLGA nanoparticle encapsulating outer membrane protein (Omp) from Aeromonas hydrophila: Evaluation of immunostimulatory action in Labeo rohita (rohu).
Rauta PR; Nayak B
Fish Shellfish Immunol; 2015 May; 44(1):287-94. PubMed ID: 25689492
[TBL] [Abstract][Full Text] [Related]
51. PLGA-PEI nanoparticles for gene delivery to pulmonary epithelium.
Bivas-Benita M; Romeijn S; Junginger HE; Borchard G
Eur J Pharm Biopharm; 2004 Jul; 58(1):1-6. PubMed ID: 15207531
[TBL] [Abstract][Full Text] [Related]
52. Inhalable DNase I microparticles engineered with biologically active excipients.
Osman R; Al Jamal KT; Kan PL; Awad G; Mortada N; El-Shamy AE; Alpar O
Pulm Pharmacol Ther; 2013 Dec; 26(6):700-9. PubMed ID: 23933140
[TBL] [Abstract][Full Text] [Related]
53. Sodium colistimethate loaded lipid nanocarriers for the treatment of Pseudomonas aeruginosa infections associated with cystic fibrosis.
Pastor M; Moreno-Sastre M; Esquisabel A; Sans E; Viñas M; Bachiller D; Asensio VJ; Pozo AD; Gainza E; Pedraz JL
Int J Pharm; 2014 Dec; 477(1-2):485-94. PubMed ID: 25445528
[TBL] [Abstract][Full Text] [Related]
54. Co-delivery of chemotherapeutic drugs with vitamin E TPGS by porous PLGA nanoparticles for enhanced chemotherapy against multi-drug resistance.
Zhu H; Chen H; Zeng X; Wang Z; Zhang X; Wu Y; Gao Y; Zhang J; Liu K; Liu R; Cai L; Mei L; Feng SS
Biomaterials; 2014 Feb; 35(7):2391-400. PubMed ID: 24360574
[TBL] [Abstract][Full Text] [Related]
55. Delivery of photosensitisers and light through mucus: investigations into the potential use of photodynamic therapy for treatment of Pseudomonas aeruginosa cystic fibrosis pulmonary infection.
Donnelly RF; McCarron PA; Cassidy CM; Elborn JS; Tunney MM
J Control Release; 2007 Feb; 117(2):217-26. PubMed ID: 17196290
[TBL] [Abstract][Full Text] [Related]
56. Poly(lactide- co-glycolide) Nanoparticles for Prolonged Therapeutic Efficacy of Esculentin-1a-Derived Antimicrobial Peptides against Pseudomonas aeruginosa Lung Infection: in Vitro and in Vivo Studies.
Casciaro B; d'Angelo I; Zhang X; Loffredo MR; Conte G; Cappiello F; Quaglia F; Di YP; Ungaro F; Mangoni ML
Biomacromolecules; 2019 May; 20(5):1876-1888. PubMed ID: 31013061
[TBL] [Abstract][Full Text] [Related]
57. Calcium phosphate embedded PLGA nanoparticles: a promising gene delivery vector with high gene loading and transfection efficiency.
Tang J; Chen JY; Liu J; Luo M; Wang YJ; Wei XW; Gao X; Wang BL; Liu YB; Yi T; Tong AP; Song XR; Xie YM; Zhao Y; Xiang M; Huang Y; Zheng Y
Int J Pharm; 2012 Jul; 431(1-2):210-21. PubMed ID: 22561795
[TBL] [Abstract][Full Text] [Related]
58. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.
Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J
ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015
[TBL] [Abstract][Full Text] [Related]
59. Design of smart GE11-PLGA/PEG-PLGA blend nanoparticulate platforms for parenteral administration of hydrophilic macromolecular drugs: synthesis, preparation and in vitro/ex vivo characterization.
Colzani B; Speranza G; Dorati R; Conti B; Modena T; Bruni G; Zagato E; Vermeulen L; Dakwar GR; Braeckmans K; Genta I
Int J Pharm; 2016 Sep; 511(2):1112-23. PubMed ID: 27511710
[TBL] [Abstract][Full Text] [Related]
60. Nano into Micro Formulations of Tobramycin for the Treatment of Pseudomonas aeruginosa Infections in Cystic Fibrosis.
Porsio B; Cusimano MG; Schillaci D; Craparo EF; Giammona G; Cavallaro G
Biomacromolecules; 2017 Dec; 18(12):3924-3935. PubMed ID: 29111673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
